(Q33401624)

26 July 2017

title

Pulsed high-dose dexamethasone improves interleukin 10 secretion by CD5+ B cells in patients with primary immune thrombocytopenia (English)

1 reference

26 July 2017

0 references

1 reference

1 reference

Fanli Hua

1

1 reference

26 July 2017

Lili Ji

2

1 reference

26 July 2017

Yanxia Zhan

3

1 reference

26 July 2017

Feng Li

4

1 reference

26 July 2017

Shanhua Zou

5

1 reference

26 July 2017

Xiaoyun Wang

6

1 reference

26 July 2017

Dongli Song

7

1 reference

26 July 2017

Zhihui Min

8

1 reference

26 July 2017

Song Gao

9

1 reference

26 July 2017

Yangjiong Wu

10

1 reference

26 July 2017

Hao Chen

11

1 reference

26 July 2017

Yunfeng Cheng

12

1 reference

26 July 2017

publication date

6 June 2012

1 reference

Journal of Clinical Immunology

26 July 2017

published in

1 reference

26 July 2017

volume

32

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

1233-1242

1 reference

Chronic idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications for therapy

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Immune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

ITP: a historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

B cells regulate autoimmunity by provision of IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Cell type-specific regulation of IL-10 expression in inflammation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Regulation of immunity and autoimmunity by B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

B-1 B cells: development, selection, natural autoantibody and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

CD5: a safeguard against autoimmunity and a shield for cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

International consensus report on the investigation and management of primary immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcgamma receptors on monocytes in patients with primary immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Correction of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Dexamethasone inhibits immunoreactivity of dendritic cells in patients with chronic idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

High-dose dexamethasone regulates interleukin-18 and interleukin-18 binding protein in idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

High-dose dexamethasone inhibits BAFF expression in patients with immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Effects of high-dose dexamethasone on regulating interleukin-22 production and correcting Th1 and Th22 polarization in immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Increased numbers of CD5+ B lymphocytes with a regulatory phenotype in spondylarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

B cells expressing CD5 antigen are markedly increased in peripheral blood and spleen lymphocytes from patients with immune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Both splenic CD5(+) B and CD5(-) B cells produce platelet glycoprotein-specific autoantibodies in chronic ITP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Human T cells induce their own regulation through activation of B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9714-Z

Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes

21 January 2018

1 reference

12 December 2020

Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production

1 reference

12 December 2020

Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjögren's syndrome

1 reference

12 December 2020

Autoantibodies and CD5+ B cells in childhood onset immune thrombocytopenic purpura

1 reference

12 December 2020

Clinical significance of serum cytokine levels and thrombopoietic markers in childhood idiopathic thrombocytopenic purpura

1 reference

12 December 2020

The Leu-1 B-cell subpopulation in patients with rheumatoid arthritis

1 reference

12 December 2020

What are regulatory B cells?

1 reference

12 December 2020

Pathophysiology and therapeutic options in primary immune thrombocytopenia

1 reference

12 December 2020

10.1007/S10875-012-9714-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1046573104

0 references

1 reference